Daniel Brasseur
Biographic Data
| ID | 5466363 |
|---|---|
| NAME | Daniel Brasseur |
| GIVEN NAMES | Daniel |
| FAMILY NAME | Brasseur |
| SIGNATURE | BRASSEUR D |
| AFFILIATIONS | Independent Advisor, Brussels, Belgium |
| ORCID | 0000-0002-4065-0943 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2012 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Collaboration within the global vaccine safety surveillance ecosystem during the Covid-19 pandemic
This analysis describes the successes, challenges and opportunities to improve global vaccine safety surveillance as observed by the Vaccine Safety Working Group from its role as a platform of exchange for stakeholders responsible for monitoring the safety of vaccines distributed through the COVAX mechanism. Three key elements considered to be essential for ongoing and future pandemic preparedness for vaccine developers in their interaction with …
‘Over’ or ‘bad’-nutrition
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button
Drug therapy
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button
No prominent works on this page.
‘Over’ or ‘bad’-nutrition
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button
Drug therapy
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button
Collaboration within the global vaccine safety surveillance ecosystem during the Covid-19 pandemic
This analysis describes the successes, challenges and opportunities to improve global vaccine safety surveillance as observed by the Vaccine Safety Working Group from its role as a platform of exchange for stakeholders responsible for monitoring the safety of vaccines distributed through the COVAX mechanism. Three key elements considered to be essential for ongoing and future pandemic preparedness for vaccine developers in their interaction with …
Computer Science (2 works) · Mathematics (2 works) · Medicine (2 works) · Adverse effect (1 work) · Business (1 work) · Environmental health (1 work) · Heparin-Induced Thrombocytopenia and Thrombosis (1 work) · Immunization (1 work) · Immunology (1 work) · Intramuscular injections and effects (1 work)